Treatment of myocardial dysfunction in sepsis: the Toll-like receptor antagonist approach

Shock. 2011 Dec;36(6):633-4. doi: 10.1097/SHK.0b013e318237a37b.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Disaccharides / therapeutic use*
  • Endotoxemia / drug therapy*
  • Female
  • Male
  • Sepsis / drug therapy*
  • Sugar Phosphates / therapeutic use*
  • Toll-Like Receptor 4 / antagonists & inhibitors*

Substances

  • Disaccharides
  • Sugar Phosphates
  • Toll-Like Receptor 4
  • eritoran